EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access · CC BY-NC 4.0

Coronary arterial repair in patients with stable angina pectoris or acute coronary syndrome after ultrathin biodegradable polymer sirolimus‐eluting stent implantation at 1‐year follow‐up by coronary angioscopy

Minoru Ichikawa iD, Yuki Matsuoka, Terumitsu Hasebe iD

Catheterization and Cardiovascular Interventions · 2023

DOI: 10.1002/ccd.30899 ↗

At a glance

Beobachtungsstudie in Catheterization and Cardiovascular Interventions, 2023. Written by Minoru Ichikawa and 2 co-authors. Institution: Department of Cardiology, Higashi-Osaka City Medical Center, Osaka, Japan. Major MEDLINE topics: Angina, Stable, Drug-Eluting Stents, Acute Coronary Syndrome, Coronary Artery Disease. 28 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Imaging modality‐based evidence is limited that compares the extent of coronary arterial repair after percutaneous coronary intervention between patients with stable angina pectoris (SAP) and those with acute coronary syndrome (ACS).

Methods

Between December 2018 and November 2021, a single‐center, nonrandomized, observational study was conducted in 92 patients with SAP ( n = 42) or ACS ( n = 50), who were implanted with Orsiro sirolimus‐eluting stent (O‐SES) providing a hybrid (active and passive) coating and underwent 1‐year follow‐up by coronary angioscopy (CAS) after implantation. CAS assessed neointimal coverage (NIC), maximum yellow plaque (YP), and mural thrombus (MT).

Results

Baseline clinical characteristics were comparable between the SAP and ACS groups. The follow‐up periods were comparable between the two groups (390.1 ± 69.9 vs. 390.6 ± 65.7 days, p = 0.99). The incidences of MT at 1 year after implantation were comparable between the two groups (11.4% vs. 11.1%, p = 0.92). The proportions of “Grade 1” in dominant NIC grades were highest in both groups, and the proportions of maximum YP grades and MT were comparable between the two groups.

Conclusion

O‐SES‐induced coronary arterial repair at the site of stent implantation, irrespective of the types of coronary artery disease.

Subjects

MeSH terms (MEDLINE)

Angina, StableDrug-Eluting StentsAcute Coronary SyndromeCoronary Artery DiseasePercutaneous Coronary InterventionThrombosisHumansSirolimusAngioscopyFollow-Up StudiesCoronary AngiographyTreatment OutcomeNeointimaPolymers

Author keywords

acute coronary syndromecoronary angioscopyneointimal coveragestable angina pectorisultrathin strut

Substances

SirolimusPolymers

Authors and institutions

  • Department of Cardiology, Higashi-Osaka City Medical Center, Osaka, Japan.
  • Department of Radiology, Tokai University School of Medicine, Kanagawa, Japan.
  • Department of Radiology, Tokai University Hachioji Hospital, Tokyo, Japan.
  • Vascular and Interventional Center, Tokai University Hachioji Hospital, Tokyo, Japan.

ORCID profiles: Minoru Ichikawa, Terumitsu Hasebe

Cite

APA

Ichikawa, M., Matsuoka, Y., & Hasebe, T. (2023). Coronary arterial repair in patients with stable angina pectoris or acute coronary syndrome after ultrathin biodegradable polymer sirolimus‐eluting stent implantation at 1‐year follow‐up by coronary angioscopy. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30899

Vancouver

Ichikawa M, Matsuoka Y, Hasebe T. Coronary arterial repair in patients with stable angina pectoris or acute coronary syndrome after ultrathin biodegradable polymer sirolimus‐eluting stent implantation at 1‐year follow‐up by coronary angioscopy. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30899

BibTeX
@article{Ichikawa2023,
  author = {Ichikawa, Minoru and Matsuoka, Yuki and Hasebe, Terumitsu},
  title = {Coronary arterial repair in patients with stable angina pectoris or acute coronary syndrome after ultrathin biodegradable polymer sirolimus‐eluting stent implantation at 1‐year follow‐up by coronary angioscopy},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30899}
}
Start for free →